During the past decade, Global Research Partners conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Global Research Partners" are "Hypertension" (2 trials). Many other conditions were trialed in "Global Research Partners" in a lesser frequency.

Most popular intervention types in "Global Research Partners" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Darusentan" (2 trials) and "Darusentan Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Global Research Partners" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Global Research Partners". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Global Research Partners, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Global Research Partners, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".